If I notice particulates in an autologous unit of blood after storage, may I use it?
As mentioned above, it is FDA’s thinking that autologous units with observed particulates may be used after the blood products are filtered using procedures that are adequate to remove white cells. As always, the medical director should use discretion and the concerns of the patient should be addressed.
